Tourmaline Bio’s Post

View organization page for Tourmaline Bio, graphic

11,212 followers

Tourmaline Bio has just presented our latest poster at the American Society for Preventive Cardiology (ASPC) Congress, highlighting the design and rationale of our Phase 2 TRANQUILITY trial. This trial builds on data from six previous studies and is an important step forward in understanding how IL-6 pathway inhibition could lower cardiovascular risk in high-risk patients with chronic kidney disease. Read more about the TRANQUILITY trial design here: https://bit.ly/46uyukY #ASPC2024 #clinicaltrial #drugdiscovery

  • No alternative text description for this image
Coleen Glessner

EVP, Quality, Ethics and Compliance, Emergent BioSolutions

2mo

LOVE seeing this, Sandeep Kulkarni !

Like
Reply

To view or add a comment, sign in

Explore topics